Badari Ganti
About Badari Ganti
Badari Ganti is the Head of Commercial Analytics & Operations and Executive Director at Pharmacyclics, an AbbVie Company, with extensive experience in the pharmaceutical industry.
Title and Current Positions
Badari Ganti holds the title of Director and currently works at Pharmacyclics, an AbbVie Company. In his role, he leads Commercial Analytics & Operations in the United States. Additionally, he serves as Executive Director at the company's Sunnyvale location.
Professional Experience at Bristol-Myers Squibb
Before joining Pharmacyclics, Badari Ganti worked at Bristol-Myers Squibb. He served as a Director, and previously as an Associate Director from 2010 to 2013. His tenure at Bristol-Myers Squibb spanned several years, providing him with extensive experience in commercial analytics within the pharmaceutical industry.
Career at ZS Associates
Badari Ganti spent two years (2008-2010) as a Manager at ZS Associates. During his time at the company, he was responsible for leading various projects, contributing to the firm's consulting offerings, and enhancing his skills in management and operations.
Educational Background
Badari Ganti has a strong educational foundation. He earned his MSE in Operations Research & Financial Engineering from Princeton University, where he also achieved a Master of Science in Engineering and a Master of Science (MS) in Engineering. He further enhanced his knowledge and skills at NYU Stern School of Business from 2005 to 2008. Additionally, he studied at the Indian Institute of Technology, Madras.
Joining Pharmacyclics
Badari Ganti joined Pharmacyclics, an AbbVie Company, in April 2019. Since then, he has been leading the Commercial Analytics & Operations division, leveraging his extensive experience in the pharmaceutical industry to drive operational efficiency and analytical capabilities.
Expertise in Commercial Analytics and Operations
With years of experience in commercial analytics and operations, Badari Ganti has built a reputable career in the pharmaceutical industry. His roles at Pharmacyclics and Bristol-Myers Squibb have allowed him to develop a deep understanding of the commercial landscape and operational strategies necessary for success in this field.